Purchase Order HHSN302201700027P

<p>The National Human Genome Research Institute issued a $149,618.50 delivery order to Illumina, Inc., on September 1, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 30, 2017.</p>

<p>The National Human Genome Research Institute issued a $5,450.23 delivery order to Illumina, Inc. on August 15, 2018, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order carries a firm fixed-price structure and an ultimate completion date of September 14, 2018.</p>

<p>The National Human Genome Research Institute issued a $122,145.01 delivery order to Illumina, Inc. on September 15, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order has a firm fixed-price structure with an ultimate completion date of December 15, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Eurofins Genomics LLC for $14,975.00 on December 13, 2016, with a firm fixed price for research studies. Place of performance is Bethesda, Maryland. The order was not set-aside and carries an ultimate completion date of January 11, 2021.</p>

<p>The National Human Genome Research Institute issued a $105,412.33 delivery order to Illumina, Inc. on September 14, 2017, for genetic sequencing and genomic analysis equipment and consumables.</p> <p>Place of performance is North Bethesda, MD. The order is firm fixed price with an ultimate completion date of January 31, 2018. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a $13,029.68 delivery order to Illumina, Inc. on September 12, 2017, for genetic sequencing and genomic analysis equipment and supplies.</p> <p>Place of performance is North Bethesda, Maryland. The order has a firm fixed-price structure and an ultimate completion date of October 11, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a purchase order to the Trustees of the University of Pennsylvania on June 28, 2016, with a ceiling value of $4,129.20 and firm fixed pricing. Place of performance is Bethesda, Maryland. The order was completed by December 21, 2020. No set-aside designation was used.</p>

<p>The National Human Genome Research Institute issued a $147,003.32 delivery order to Illumina, Inc. on September 12, 2017, for genetic sequencing and genomic analysis technologies. Place of performance is North Bethesda, MD. The order has a firm fixed price and ultimate completion date of October 11, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a $98,905.32 delivery order to Illumina, Inc. on August 22, 2019, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order is firm fixed-price with an ultimate completion date of September 2, 2020. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on November 28, 2017, with a ceiling value of $52,494.10 for genetic sequencing and genomic analysis technologies and services.</p> <p>Place of performance is Bethesda, MD 20892. The order was priced on a firm fixed-price basis with an ultimate completion date of September 2, 2020. No set-aside was used for this delivery order.</p>